How often should a complete blood count (CBC) be checked while taking imatinib?
Generally, during imatinib treatment, it is recommended to perform a complete blood count (CBC) once a week, with close monitoring required for at least the first three months. If the condition remains stable, the frequency of testing may gradually be reduced; however, regular check-ups are still necessary to ensure the drug's efficacy and safety.
Imatinib is a targeted therapy drug commonly used to treat chronic myeloid leukemia and certain types of gastrointestinal stromal tumors. It is also effective in treating certain subtypes of acute lymphoblastic leukemia. Regular CBC tests are required during imatinib treatment to monitor both therapeutic response and potential side effects.
It should be noted that imatinib may affect the hematopoietic system, leading to decreases in white blood cells, red blood cells, and platelets. Therefore, blood counts must be closely monitored during treatment to promptly detect and manage any abnormalities. Patients should seek medical attention immediately if they experience any discomfort or have concerns.